News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
Are you interested in learning about how to license from or collaborate with the NIH? Since the 1970s, the Intramural Research Program (IRP) has served as the in-house research and clinical arm of the NIH. Despite our success, many potential industry collaborators and licensees still see NIH solely
The Federal Laboratory Consortium for Technology Transfer (FLC) has released a new podcast episode discussing one of the many ways the FLC provides value for federal labs and their business partners and collaborators. This podcast discusses the FLC hosting a pavilion at the Biotechnology Innovation
NIH is proposing to develop and implement a new policy within the NIH’s Intramural Research Program, the internal research arm of the agency. The policy would require organizations partnering with NIH through a patent licensing agreement that succeed in bringing certain products to market to submit